PolyNovo Biomaterials Pty Limited has announced that three specialist plastic surgeons at the Royal Adelaide Hospital have been granted authorization by the Therapeutic Goods Administration (TGA) to prescribe PolyNovo’s Biodegradable Temporising Matrix (BTM) wound implant in free flap donor sites. The BTM finds use in the care of burns and other wounds and the authorization is prior to full marketing approval.

PolyNovo is the holder of a patent portfolio in the area of biocompatible and biodegradable polymers. Watermark has worked with PolyNovo for several years developing this commercially and strategically valuable portfolio and we are very pleased to see such a positive development in relation to their BTM technology.